Article
Low dose methotrexate impaired T cell transmigration through down-regulating CXCR4 expression in rheumatoid arthritis
2023-11-28
Abstract excerpt
<title>Abstract</title> <p>Background CXC chemokine CXCL12 is involved in the pathological development of rheumatoid arthritis (RA) through abnormal migration of peripheral immune cells in the joint. Although low dose methotrexate (MTX) is clinically used to treat RA patients, CXCL12 signaling responses to MTX-mediated treatments is still controversial. Methods In this study, we examined the expression of CXCR4...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b5bf9233-fe8f-54d8-91dc-27529bbb32b2
- DOI
- 10.21203/rs.3.rs-3649330/v1
